Cytokinetics, Incorporated (NASDAQ:CYTK) Shares Purchased by Crestline Management LP
Crestline Management LP lifted its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 74.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,887 shares of the biopharmaceutical company’s stock after acquiring an additional 14,887 shares during the quarter. Crestline […]
More Stories
Tesco PLC Declares Dividend of GBX 4.25 (LON:TSCO)
Tesco PLC (LON:TSCO – Get Free Report) announced a dividend on Thursday, October 3rd, Upcoming.Co.Uk reports. Shareholders of record on...
The Detroit Legal News Company (OTCMKTS:DTRL) Announces $2.00 Quarterly Dividend
The Detroit Legal News Company (OTCMKTS:DTRL – Get Free Report) announced a quarterly dividend on Wednesday, September 25th, NASDAQ reports....
JPMorgan Asia Growth & Income plc (LON:JAGI) to Issue Dividend of GBX 4.20
JPMorgan Asia Growth & Income plc (LON:JAGI – Get Free Report) declared a dividend on Tuesday, October 1st, Upcoming.Co.Uk reports....
Aquila Energy Efficiency Trust (LON:AEET) Announces Dividend Increase – GBX 6.14 Per Share
Aquila Energy Efficiency Trust (LON:AEET – Get Free Report) announced a dividend on Friday, September 27th, Upcoming.Co.Uk reports. Investors of...
Analysts Set CACI International Inc (NYSE:CACI) Target Price at $485.60
CACI International Inc (NYSE:CACI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven...
Corebridge Financial, Inc. (NYSE:CRBG) Receives Average Recommendation of “Moderate Buy” from Analysts
Corebridge Financial, Inc. (NYSE:CRBG – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twelve...